Miraculous
Platycodon Grandiflorus Root, Angelica Sinensis Root
Qingdao Aolixin Sanitary Products Co., Ltd.
Human Otc Drug
NDC 82672-302Miraculous also known as Platycodon Grandiflorus Root, Angelica Sinensis Root is a human otc drug labeled by 'Qingdao Aolixin Sanitary Products Co., Ltd.'. National Drug Code (NDC) number for Miraculous is 82672-302. This drug is available in dosage form of Powder. The names of the active, medicinal ingredients in Miraculous drug includes Angelica Sinensis Root - 4 g/100g Platycodon Grandiflorus Root - 5 g/100g . The currest status of Miraculous drug is Active.
Drug Information:
| Drug NDC: | 82672-302 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Miraculous |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Platycodon Grandiflorus Root, Angelica Sinensis Root |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Qingdao Aolixin Sanitary Products Co., Ltd. |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Powder |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | ANGELICA SINENSIS ROOT - 4 g/100g
PLATYCODON GRANDIFLORUS ROOT - 5 g/100g
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | ORAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | UNAPPROVED HOMEOPATHIC |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 20 Apr, 2022 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 11 Jun, 2026 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | Qingdao Aolixin Sanitary Products Co., Ltd.
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UNII: | B66F4574UG
2DF0NS0O2Z
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 82672-302-01 | 9 g in 1 BAG (82672-302-01) | 20 Apr, 2022 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Detoxification anti inflammation
Product Elements:
Miraculous platycodon grandiflorus root, angelica sinensis root scrophularia ningpoensis root adenophora stricta root scutellaria baicalensis whole impatiens balsamina seed angelica sinensis root angelica sinensis root sparganium stoloniferum root salvia miltiorrhiza root atractylodes macrocephala root manis pentadactyla scale sophora tonkinensis whole codonopsis pilosula root platycodon grandiflorus root platycodon grandiflorus root carthamus tinctorius whole dicentra canadensis root reynoutria multiflora whole turmeric fritillaria thunbergii whole taraxacum officinale paeonia x suffruticosa root cinnamon eupolyphaga sinensis ophiocordyceps sinensis dolomiaea costus root paeonia lactiflora root wolfiporia cocos whole
Indications and Usage:
Uses for the temporary relief of symptoms due to inflammation.
Warnings:
Warnings do not take more than specified amount.
Do Not Use:
Warnings do not take more than specified amount.
When Using:
When using it is normal to have diarrhea for 2-3 days.
Dosage and Administration:
Directions for those under 60 years old, take one package (9g) three times a day, two hours after breakfast and lunch, and one package (9g) 30 minutes before going to bed it is recommended to eat one package (9g) 2 hours after breakfast and one package (9g) 30 minutes before going to bed.
Stop Use:
Stop use and ask a doctor if symptoms of discomfort worsen. if you develop severe red spots or itching.
Package Label Principal Display Panel:
Label miraculous label